Close

UBS Downgrades Selecta Biosciences (SELB) to Neutral

November 9, 2017 8:12 AM EST Send to a Friend
UBS downgraded Selecta Biosciences (NASDAQ: SELB) from Buy to Neutral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login